Intestinal biopsy, coeliac disease and resistance to change
- PMID: 35048644
- DOI: 10.1097/MEG.0000000000002171
Intestinal biopsy, coeliac disease and resistance to change
Comment on
-
Serum transglutaminase antibodies do not always detect the persistent villous atrophy in patients with celiac disease on a gluten-free diet.Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e650-e655. doi: 10.1097/MEG.0000000000002194. Eur J Gastroenterol Hepatol. 2021. PMID: 34034270
-
Screening-detected positive serology for celiac disease: a real clinical challenge.Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e999-e1002. doi: 10.1097/MEG.0000000000002093. Eur J Gastroenterol Hepatol. 2021. PMID: 35048660
References
-
- Ford JD, Ford LW, D’Amelio A. Resistance to change: the rest of the story. Acad Manage Rev 2008; 33:362–377.
-
- Johansson C, Åström S, Kauffeldt A, Helldin L, Carlström E. Culture as a predictor of resistance to change: a study of competing values in a psychiatric nursing context. Health Policy 2014; 114:156–162.
-
- Green PH, Cellier C. Celiac disease. N Engl J Med 2007; 357:1731–1743.
-
- Di Sabatino A, Corazza GR. Coeliac disease. Lancet 2009; 373:1480–1493.
-
- Donat E, Roca M, Masip E, Polo B, Ramos D, Ribes-Koninckx C. Screening detected positive serology for celiac disease: a real clinical challenge. Eur J Gastroenterol Hepatol 2021. [Epub ahead of print]